Cellex is an innovative start-up Company founded in June 2018.
Its core business is the development of bioreactors for advanced cell culture and tissue engineering. Cellex is currently focused on the design, development and production of SUSPENCE®, a highly innovative scalable bioreactor that keeps cells in suspension in a culture chamber, allowing them to grow and reach maturity in dynamic conditions.
Cellex owns the property rights and the know-how gained through previous projects carried out by the founding team while working for different Research Institutions and Companies and holds one national patent, one international patent and one registered trademark.
Currently, 100% of Cellex’ business profit is invested in research and development, resulting in one of the most innovative Companies in Europe, according to the IMP³rove – European Innovation Management Academy.
Cellex current customers are located in Italy, Austria, Germany and Canada.